Home › Cancro al seno › Florida
Studi clinici su Cancro al seno nello stato di Florida
146 studi su Cancro al seno cercano partecipanti presso sedi nello stato di Florida.
Città nello stato di Florida
- Tampa43 studi
- Miami42 studi
- Jacksonville40 studi
- Orlando23 studi
- Plantation14 studi
- Sarasota12 studi
- Gainesville12 studi
- St. Petersburg11 studi
- Cape Coral10 studi
- Lakeland8 studi
- Deltona8 studi
- Davie7 studi
- Clearwater6 studi
- Hollywood6 studi
- Miami Beach6 studi
- West Palm Beach6 studi
- Kendall5 studi
- Deerfield Beach5 studi
- Coral Springs4 studi
- Boca Raton4 studi
- Fort Lauderdale4 studi
- Palm Bay3 studi
- Doral3 studi
- Tallahassee3 studi
Testo ufficiale dello studio (inglese)
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of Miami - Sylvester Comprehensive Cancer Center, Miami
- Advent Health, Orlando
- Florida Cancer Specialists South, Port Charlotte
In reclutamentoFase 1/2
Età 12 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT04585750Phase IIIb Study of Ribociclib + ET in Early Breast Cancer
- Holy Cross Health, Fort Lauderdale
- Memorial Cancer Institute, Hollywood
- Jupiter Medical Center, Jupiter
In reclutamentoFase 3
Età da 18 a 100 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05827081Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mount Sinai Comprehensive Cancer Center at Aventura, Aventura
- Schulze Family Foundation Cancer Clinic - Bonita Health Center, Bonita Springs
- Morton Plant Hospital, Clearwater
- e altri 11
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 75 · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT05334069A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus, Fort Myers
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 2 ott 2026 · NCT06760819A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- AdventHealth Medical Group Oncology Research at Celebration, Kissimmee
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06172478A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
- Holy Cross Hospital, Fort Lauderdale
- The Oncology Institute, Lakeland
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT07102381Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- Moffitt Cancer Center, Tampa
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06625775Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 2Volontari sani benvenuti
Età da 18 a 45 · Donne · Aggiornato il 1 ott 2026 · NCT05557877A Study of Alisertib in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Recurrent or Metastatic Breast Cancer
- Mayo Clinic Florida, Jacksonville
- Cancer Specialists of North Florida, Jacksonville
- Moffitt Cancer Center, Tampa
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 1 ott 2026 · NCT06369285Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread
- Helios CR Inc, Lakeland
- H. Lee Moffitt Cancer Center and Research Institute, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT06324357The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 30 set 2026 · NCT07285044Conventionally Fractionated vs. Hypofractionated Comprehensive Nodal Irradiation for Breast Cancer Using Pencil Beam Scanning Proton Therapy
- University of Florida Proton Therapy Institute, Jacksonville
- Dwoskin Proton Therapy Center, Miami
- Miami Cancer Institute, Miami
In reclutamentoFase 3
Età 19 e oltre · Donne · Aggiornato il 29 set 2026 · NCT05856773A Study of NT-175 in Adult Participants With Advanced Malignancies That Are Positive for HLA-A*02:01 and the TP53 R175H Mutation
- Research Site, Jacksonville
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT05877599A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
- Florida Cancer Specialists & Research Institute - Sarasota Cattlemen, Sarasota
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 29 set 2026 · NCT07578571Study of AVZO-021 in Patients With Advanced Solid Tumors
- Avenzo Therapeutics Recruiting Site, Sarasota
- Avenzo Therapeutics Recruiting Site, Tampa
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT05867251A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0024), Altamonte Springs
- Comprehensive Hematology Oncology ( Site 0060), St. Petersburg
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 28 set 2026 · NCT07060807Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy
- Baptist MD Anderson Cancer Center, Jacksonville
In reclutamento
Età 30 e oltre · Donne · Aggiornato il 25 set 2026 · NCT02945579A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- AdventHealth Medical Group Oncology and Hematology at Altamonte ( Site 0044), Altamonte Springs
- Florida Cancer Specialists - South ( Site 7004), Fort Myers
- Bioresearch Partner ( Site 0072), Hialeah
- e altri 2
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06966700A Study of Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)
- AdventHealth Altamonte Springs ( Site 0021), Altamonte Springs
- Orlando Health Cancer Institute ( Site 0011), Orlando
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06312176The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
- Miami Cancer Institute, Miami
- Miami Cancer Institute, Plantation
In reclutamentoFase 3
Età 60 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06377852A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
- Research Site, Altamonte Springs
- Research Site, Miami
- Research Site, Plantation
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT06103864Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
- Morton Plant Hospital - Baycare Health System, Clearwater
- Moffitt Cancer Center, Tampa
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT05528133ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
- Mayo Clinic, Jacksonville
- Sylvester Comprehensive Cancer Center, Miami
- Moffitt Cancer Center, Tampa
In reclutamentoFase 2
Età 18 e oltre · Tutti i sessi · Aggiornato il 25 set 2026 · NCT07007559A Study to Compare the Steady-State Bioavailability of Injectable Letrozole SIE and Oral Letrozole in Post-Menopausal Women With Hormone Receptor Positive Early Breast Cancer
- D&H National Research Centers INC (Investigational Site number USA-002), Margate
- United Medical Research (Investigational Site number USA-005), Port Orange
In reclutamentoFase 1
Età da 18 a 80 · Donne · Aggiornato il 23 set 2026 · NCT07401381Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)
- University of Miami, Coral Gables
In reclutamento
Età 50 e oltre · Donne · Aggiornato il 23 set 2026 · NCT07502352A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
- University of Miami Hospital and Clinics, Sylvester Cancer Center, Miami
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06618287Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
- Clinical Trial Site, Tampa
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07085767Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
- Baptist MD Anderson, Jacksonville
- Mayo Clinic Florida, Jacksonville
- Jupiter Medical Cancer, Jupiter
- e altri 2
In reclutamento
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT07214532Precise Oncology Interventions in Nutrition and Training (OnPoint)
- University of Miami, Miami
In reclutamentoVolontari sani benvenuti
Età 18 e oltre · Tutti i sessi · Aggiornato il 23 set 2026 · NCT06534918A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
- AdventHealth Altamonte Springs, Altamonte Springs
- Clermont Oncology Center, Clermont
- Florida Oncology & Hematology, Fort Myers
- e altri 4
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07174336A Study of LY4257496 in Participants With Cancer (OMNIRAY)
- Moffitt, Tampa
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07114601A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer
- AdventHealth Altamonte Springs, Altamonte Springs
- Mayo Clinic in Florida, Jacksonville
In reclutamentoFase 2
Età 18 e oltre · Donne · Aggiornato il 22 set 2026 · NCT07287098A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
- Moffitt, Tampa
In reclutamentoFase 1
Età 18 e oltre · Tutti i sessi · Aggiornato il 22 set 2026 · NCT07213791A Study of JNJ-101684362 (HLD-0117) in Patients With Metastatic Breast Cancer
- Florida Cancer Specialists, Sarasota
In reclutamentoFase 1
Età 18 e oltre · Donne · Aggiornato il 21 set 2026 · NCT07524855Women Informed to Screen Depending on Measures of Risk (Wisdom Study)
- TopLine MD Alliance, Miami
In reclutamentoVolontari sani benvenuti
Età da 30 a 74 · Donne · Aggiornato il 21 set 2026 · NCT02620852Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
- Baptist Alliance Miami Cancer Institute, Miami
In reclutamentoFase 2
Età 45 e oltre · Donne · Aggiornato il 21 set 2026 · NCT04084730Identifying Patterns in the Breath of Individuals With Breast Cancer
- Mayo Clinic Breast Clinic, Jacksonville
In reclutamentoStudio osservazionaleVolontari sani benvenuti
Età da 40 a 74 · Donne · Aggiornato il 18 set 2026 · NCT06512350ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
- Florida Cancer Specialists, Fort Myers
- Cancer Care Centers of Brevard, Inc, Palm Bay
- Sacred Heart Medical Oncology Group, Pensacola
- e altri 1
In reclutamentoFase 3
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07173751A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
- Florida Cancer Specialists - Lake Nona, Orlando
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT07109726A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer
- Hematology - Oncology Associates of the Treasure Coast, Port Saint Lucie
In reclutamentoFase 1/2
Età 18 e oltre · Tutti i sessi · Aggiornato il 17 set 2026 · NCT06827236Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.